{"id":"gw642444-6-25","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL3979785","moleculeType":"Small molecule","molecularWeight":"551.53"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"GW642444 works by binding to the glucagon receptor, thereby inhibiting glucagon's action and reducing glucose levels in the blood. This mechanism is thought to be beneficial for the treatment of type 2 diabetes.","oneSentence":"GW642444 is a glucagon receptor antagonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:02:19.222Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT00702910","phase":"PHASE1","title":"A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-04-27","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":24},{"nctId":"NCT00606684","phase":"PHASE2","title":"A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-02","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":602}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"GW642444 6.25","genericName":"GW642444 6.25","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"GW642444 is a glucagon receptor antagonist. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}